Скачать с ютуб Webinar: Understanding Follicular Lymphoma Clinical Trials в хорошем качестве

Webinar: Understanding Follicular Lymphoma Clinical Trials

This engaging session, which took place on Tuesday, July 23rd, provided attendees with valuable perspectives and the chance to connect with the follicular lymphoma community. The webinar featured an esteemed panel, including Dr. Mitchell Smith, FLF’s Chief Medical Officer, and Professor Jessica Okosun, an FLF Scientific Advisor, who shared specialist insights. They were joined by Ms. Nicky Greenhalgh, Founder of the “Living with FL” Facebook group, and Simon Earle, FLF Super Supporter and Patient Advocate, who provided invaluable patient perspectives. Open to everyone, the webinar was particularly beneficial for patients, families, and caregivers. It catered to those making treatment decisions or those who had not yet started treatment, offering a deeper understanding of clinical trials to empower and enhance their patient journey. The highlights of the webinar included: Learning from expert clinicians in follicular lymphoma Gaining valuable insights into clinical trials Hearing inspiring patient stories Getting questions answered Connecting with the follicular lymphoma community Comment below with what you liked about this webinar and what you'd like to see discussed in our future webinars! 💜 If you're unsure about any of the terms and treatments discussed, please visit our glossary: https://www.theflf.org/your-support-h.... You can register for upcoming webinars when available on our website here: https://www.theflf.org/your-support-h... [Disclaimer: This video is intended for educational and disease awareness purposes only and the information presented and discussed does not constitute medical advice. The presentations contain data and information regarding not yet approved treatments and/or off-label use which are not to be construed as recommendations. Please consult with your healthcare provider for medical advice.] This webinar series is supported by an educational grant from Genmab US, Inc and AbbVie and sponsorship from BeiGene USA, Inc., Novartis and Kite Gilead. This Clinical Trials webinar has also been sponsored by Ipsen and BioInvent International AB. All of the above have had no influence on, control of, nor input into the development or performance of the webinar series.